Introductory Statement
This Amendment No. 1 (this “Amendment”) amends and supplements the Issuer Tender Offer Statement on Schedule TO filed with the Securities and Exchange Commission (the “Commission”) by BlackRock Multi-Sector Opportunities Trust, a Delaware statutory trust (the “Trust”), on July 9, 2021 (the “Schedule TO”) and relates to the Trust’s offer to repurchase 2.5% of its issued and outstanding common shares of beneficial interest as of July 2, 2021, par value $0.001 per share (the “Shares”), in exchange for cash at a price equal to the net asset value (“NAV”) per Share (the “Purchase Price”) determined as of the close of the regular trading session of the New York Stock Exchange (the “NYSE”) on the day the offer expires (the “Pricing Date”), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated July 9, 2021 (the “Original Offer to Purchase”), and in the related Letter of Transmittal, copies of which were previously filed as exhibits to the Schedule TO, and in the Supplement No. 1 to the Offer to Purchase, dated July 28, 2021 (the “Supplement” and together with the Original Offer to Purchase, the “Offer to Purchase”), a copy of which is filed as an exhibit to this Amendment.
The Trust has determined to extend the Expiration Date of the Offer from 5:00 p.m., Eastern Time, on August 10, 2021, to 5:00 p.m., Eastern Time, on August 25, 2021, unless further extended by the Trust. Therefore, the Schedule TO is hereby amended and supplemented to replace all references to an Expiration Date of 5:00 p.m., Eastern Time, on August 10, 2021, with references to an Expiration Date of 5:00 p.m., Eastern Time, on August 25, 2021.
As a result of the extension of the Expiration Date, the Pricing Date for the Offer will be the close of ordinary trading on the New York Stock Exchange on August 25, 2021, unless the Offer is further extended. In addition, as a result of the extension of the Expiration Date, shareholders that tender Shares pursuant to the Offer will not be entitled to receive any Trust dividend or distribution with a record date on or after August 31, 2021.
Except as set forth in this Amendment (and in the Supplement), all other terms of the Offer, as described in the Original Offer to Purchase and related Letter of Transmittal, remain the same. Capitalized terms used herein and not otherwise defined have the meanings ascribed to such terms in the Offer to Purchase or the Schedule TO. This Amendment should be read together with the Schedule TO and the Offer to Purchase.
This Amendment is being filed in satisfaction of the requirements of Rule 13e-4(c)(1) and (c)(3) promulgated under the Securities Exchange Act of 1934, as amended.
Item 1 through Item 9 and Item 11.
The information set forth in the Offer to Purchase (as amended by the Supplement) and the related Letter of Transmittal is incorporated herein by reference into this Amendment in answer to Item 1 through Item 9 and Item 11 of Schedule TO.
Item 10. | Financial Statements |
Not applicable.
- 2 -